| Literature DB >> 33718288 |
Sarah Sze Wah Wong1,2, Lakshmi Prabha Venugopalan3, Audrey Beaussart4, Anupama Karnam5, Mohammed Razeeth Shait Mohammed3, Jeya Maheshwari Jayapal3, Stéphane Bretagne2, Jagadeesh Bayry5, Lalitha Prajna6, Dharmalingam Kuppamuthu3, Jean-Paul Latgé1, Vishukumar Aimanianda1,2.
Abstract
Although belong to the same genus, Aspergillus fumigatus is primarily involved in invasive pulmonary infection, whereas Aspergillus flavus is a common cause of superficial infection. In this study, we compared conidia (the infective propagules) of these two Aspergillus species. In immunocompetent mice, intranasal inoculation with conidia of A. flavus resulted in significantly higher inflammatory responses in the lungs compared to mice inoculated with A. fumigatus conidia. In vitro assays revealed that the dormant conidia of A. flavus, unlike A. fumigatus dormant conidia, are immunostimulatory. The conidial surface of A. fumigatus was covered by a rodlet-layer, while that of A. flavus were presented with exposed polysaccharides. A. flavus harbored significantly higher number of proteins in its conidial cell wall compared to A. fumigatus conidia. Notably, β-1,3-glucan in the A. flavus conidial cell-wall showed significantly higher percentage of branching compared to that of A. fumigatus. The polysaccharides ensemble of A. flavus conidial cell wall stimulated the secretion of proinflammatory cytokines, and conidial cell wall associated proteins specifically stimulated IL-8 secretion from the host immune cells. Furthermore, the two species exhibited different sensitivities to antifungal drugs targeting cell wall polysaccharides, proposing the efficacy of species-specific treatment strategies. Overall, the species-specific organization of the conidial cell wall could be important in establishing infection by the two Aspergillus species.Entities:
Keywords: Aspergillus; antifungal; cell-wall organization; conidia; drug susceptibility; immunoreactivity; polysaccharides
Mesh:
Year: 2021 PMID: 33718288 PMCID: PMC7950546 DOI: 10.3389/fcimb.2021.643312
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293